[EN] ALKYNYL PHENYL DERIVATIVE COMPOUNDS FOR TREATING OPHTHALMIC DISEASES AND DISORDERS [FR] DÉRIVÉS D'ALCYNYLPHÉNYLE POUR TRAITER LES MALADIES ET LES AFFECTIONS OPHTALMIQUES
Alkynyl phenyl derivative compounds for treating ophthalmic diseases and disorders
申请人:Scott Ian Leslie
公开号:US20090062353A1
公开(公告)日:2009-03-05
Provided are alkynyl phenyl derivative compounds, pharmaceutical compositions thereof, and methods of treating ophthalmic diseases and disorders, such as age-related macular degeneration and Stargardt's Disease, using said compounds and compositions.
COMPOUNDS FOR TREATING OPHTHALMIC DISEASES AND DISORDERS
申请人:Scott Ian L.
公开号:US20100113539A1
公开(公告)日:2010-05-06
Provided are compounds, pharmaceutical compositions thereof, and methods of treating ophthalmic diseases and disorders, such as age-related macular degeneration and Stargardt's Disease, using said compounds and compositions.
Alkynyl Phenyl Derivative Compounds for Treating Ophthalmic Diseases and Disorders
申请人:Scott Ian Leslie
公开号:US20120004269A1
公开(公告)日:2012-01-05
Provided are alkynyl phenyl derivative compounds, pharmaceutical compositions thereof, and methods of treating ophthalmic diseases and disorders, such as age-related macular degeneration and Stargardt's Disease, using said compounds and compositions.
ALKYNYL PHENYL DERIVATIVE COMPOUNDS FOR TREATING OPHTHALMIC DISEASES AND DISORDERS
申请人:Scott Ian Leslie
公开号:US20130018077A1
公开(公告)日:2013-01-17
Provided are alkynyl phenyl derivative compounds, pharmaceutical compositions thereof, and methods of treating ophthalmic diseases and disorders, such as age-related macular degeneration and Stargardt's Disease, using said compounds and compositions.
METHODS FOR THE TREATMENT OF DIABETIC RETINOPATHY AND OTHER OPHTHALMIC DISEASES
申请人:Acucela Inc.
公开号:EP3741742A1
公开(公告)日:2020-11-25
Methods are provided herein for the treatment of ophthalmic diseases or conditions such as an ophthalmic disease or disorder associated with diabetes in a patient. Also provided herein are methods of treating retinopathy of prematurity in a patient. Further, provided herein are methods for treating wet age-related macular degeneration in a patient. The methods comprise administration of compounds disclosed herein to a patient in need thereof that inhibit or slow one or more signs or symptoms of such conditions.